BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28343420)

  • 1. Portable devices and mobile instruments for infectious diseases point-of-care testing.
    Bissonnette L; Bergeron MG
    Expert Rev Mol Diagn; 2017 May; 17(5):471-494. PubMed ID: 28343420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portable molecular diagnostic instruments in microbiology: current status.
    Zidovec Lepej S; Poljak M
    Clin Microbiol Infect; 2020 Apr; 26(4):411-420. PubMed ID: 31574340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for overcoming challenges for decentralised diagnostics in resource-limited and catastrophe settings.
    Sharma S; Crawley A; O'Kennedy R
    Expert Rev Mol Diagn; 2017 Feb; 17(2):109-118. PubMed ID: 28010145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious pathogens meet point-of-care diagnostics.
    Zarei M
    Biosens Bioelectron; 2018 May; 106():193-203. PubMed ID: 29428589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Powering point-of-care diagnostic devices.
    Choi S
    Biotechnol Adv; 2016; 34(3):321-30. PubMed ID: 26631766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases.
    Liu W; Yue F; Lee LP
    Acc Chem Res; 2021 Nov; 54(22):4107-4119. PubMed ID: 34699183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
    Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
    Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of Point-of-Care Diagnostics for Personalized Health Wellness.
    Kumar S; Nehra M; Khurana S; Dilbaghi N; Kumar V; Kaushik A; Kim KH
    Int J Nanomedicine; 2021; 16():383-402. PubMed ID: 33488077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding diagnostic delays: a qualitative study of point-of-care testing in South Africa.
    Engel N; Davids M; Blankvoort N; Pai NP; Dheda K; Pai M
    Trop Med Int Health; 2015 Apr; 20(4):493-500. PubMed ID: 25496070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of digital technologies on point-of-care diagnostics in resource-limited settings.
    Gous N; Boeras DI; Cheng B; Takle J; Cunningham B; Peeling RW
    Expert Rev Mol Diagn; 2018 Apr; 18(4):385-397. PubMed ID: 29658382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smartphones as mobile microbiological laboratories.
    Ong DSY; Poljak M
    Clin Microbiol Infect; 2020 Apr; 26(4):421-424. PubMed ID: 31610301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care Diagnostics for Farm Animal Diseases: From Biosensors to Integrated Lab-on-Chip Devices.
    Manessis G; Gelasakis AI; Bossis I
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portable microfluidic and smartphone-based devices for monitoring of cardiovascular diseases at the point of care.
    Hu J; Cui X; Gong Y; Xu X; Gao B; Wen T; Lu TJ; Xu F
    Biotechnol Adv; 2016; 34(3):305-20. PubMed ID: 26898179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smartphone-based clinical diagnostics: towards democratization of evidence-based health care.
    Hernández-Neuta I; Neumann F; Brightmeyer J; Ba Tis T; Madaboosi N; Wei Q; Ozcan A; Nilsson M
    J Intern Med; 2019 Jan; 285(1):19-39. PubMed ID: 30079527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ebola Spatial Care Path™: Accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks.
    Kost GJ; Ferguson WJ; Hoe J; Truong AT; Banpavichit A; Kongpila S
    Am J Disaster Med; 2015; 10(2):121-43. PubMed ID: 26312494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics in a digital age: an opportunity to strengthen health systems and improve health outcomes.
    Peeling RW
    Int Health; 2015 Nov; 7(6):384-9. PubMed ID: 26553825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidics Based Point-of-Care Diagnostics.
    Pandey CM; Augustine S; Kumar S; Kumar S; Nara S; Srivastava S; Malhotra BD
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 29178532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging trends in nanomaterial design for the development of point-of-care platforms and practical applications.
    Moulahoum H; Ghorbanizamani F; Beduk T; Beduk D; Ozufuklar O; Guler Celik E; Timur S
    J Pharm Biomed Anal; 2023 Oct; 235():115623. PubMed ID: 37542827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care diagnostics: an advancing sector with nontechnical issues.
    Huckle D
    Expert Rev Mol Diagn; 2008 Nov; 8(6):679-88. PubMed ID: 18999920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.